Youth Future Civic Participation in Europe: Differences Between the East and the Rest by Mirazchiyski, P, Caro, D, Sandoval-Hernández, A

Cultural, social, and economic capital constructs in international assessments: an evaluation using exploratory structural equation modeling by Caro, D, Sandoval-Hernández, A, Lüdtke, O

Political bots and the manipulation of public opinion in Venezuela by Howard, P, Forelle, M, Monroy-Hernandez, A, Savage, S

Strategies for non-parametric smoothing of the location model in mixed-variable discriminant analysis by Mahat, Nor Idayu, Krzanowski, W.J., Hernandez, A.

Get full text

A mixture of "cheats" and "co-operators" can enable maximal group benefit. by Maclean, C, Fuentes-Hernandez, A, Greig, D, Hurst, L, Gudelj, I

Social media, civic engagement, and the slacktivism hypothesis: lessons from Mexico’s “El Bronco” by Howard, P, Savage, S, Flores-Saviaga, C, Toxtli, C, Monroy-Hernández, A

A mixture of "cheats" and "co-operators" can enable maximal group benefit by MacLean, R, Fuentes-Hernandez, A, Greig, D, Hurst, L, Gudelk, I

The voltage sensitive Lc-type Ca2+ channel is functionally coupled to the exocytotic machinery. by Wiser, O, Trus, M, Hernández, A, Renström, E, Barg, S, Rorsman, P, Atlas, D

Pricing holder-extendable call options with mean-reverting stochastic volatility by Ibrahim, Siti Nur Iqmal, Hernandez, A. Diaz, O'Hara, John G., Constantinou, Nick

Get full text

Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifuncti... by Balzarini, J, Hernández, A, Roche, P, Esnouf, R, Karlsson, A, Camarasa, M, Pérez-Pérez, M

Generating comparative evidence on new drugs and devices after approval by Cipriani, A, Ioannidis, JPA, Rothwell, P, Glasziou, P, Tomlinson, A, Hernandez, A, Simes, J, Li, T, Naci, H

Chagas disease as a cause of symptomatic chronic myocardopathy in Mexican children. by Salazar-Schettino, P, Perera, R, Ruiz-Hernandez, A, Bucio Torres, M, Zamora-Gonzalez, C, Cabrera-Bravo, M, Harnden, A

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial by Becker, F, Dakin, H, Reed, S, Li, Y, Leal, J, Gustavson, S, Kartman, B, Wittbrodt, E, Gray, A, Hernandez, A, Holman, R

Multicopy plasmids allow bacteria to escape from fitness trade-offs during evolutionary innovation by Rodriguez-Beltran, J, Hernandez-Beltran, J, DelaFuente, J, Escudero, J, Fuentes-Hernandez, A, MacLean, R, Pena-Miller, R, San Millan, A

Within-trial evaluation of medical resources, costs, and quality of life among patients with type 2 diabetes participating in the exenatide study of cardiovascular event lowering (... by Reed, S, Li, Y, Dakin, H, Becker, F, Leal, J, Gustavson, S, Kartman, B, Wittbrodt, E, Mentz, R, Pagidipati, N, Bethel, M, Gray, A, Holman, R, Hernandez, A

Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL by Reed, S, Li, Y, Dakin, H, Becker, F, Leal, J, Gustavson, S, Kartman, B, Wittbrodt, E, Mentz, R, Pagidipati, N, Bethel, M, Gray, A, Holman, R, Hernandez, A

EXSCEL—once-weekly exenatide reduces medical resource utilization in patients with type 2 diabetes mellitus by Reed, S, Li, Y, Dakin, H, Becker, F, Leal, J, Gustavson, S, Kartman, B, Wittbrodt, E, Mentz, R, Pagidipati, N, Bethel, M, Gray, A, Holman, R, Hernandez, A

International study of definitions of English-language terms for suicidal behaviours: a survey exploring preferred terminology. by De Leo, D, Goodfellow, B, Silverman, M, Berman, A, Mann, J, Arensman, E, Hawton, K, Phillips, MR, Vijayakumar, L, Andriessen, K, Chavez-Hernandez, A-M, Heisel, M, Kolves, K

Assessment of bone health in patients with type 1 gaucher disease using impact microindentation by Herrera, S, Pérez-López, J, Moltó-Abad, M, Güerri-Fernández, R, Cabezudo, E, Novelli, S, Esteve, J, Hernández, A, Roig, I, Solanich, X, Prieto-Alhambra, D, Nogués, X, Díez-Pérez, A

Bone material strength index by microin-dentation correlates with chitotriosidase levels in patients with type 1 Gaucher disease by Diez-Perez, A, Herrera, S, Perez-Lopez, J, Molto-Abad, M, Guerri-Fernandez, R, Cabezudo, E, Novelli, S, Esteve, J, Hernandez, A, Roig, I, Solanich, X, Prieto-Alhambra, D, Nogues, X